ONC
BeOne Medicines AG (ONC) reported net income of $286.93M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $286.93M | +144.5% |
| FY 2024 | -$644.79M | +26.9% |
| FY 2023 | -$881.71M | +56.0% |
| FY 2022 | -$2.00B | -37.5% |
| FY 2021 | -$1.46B | +10.3% |
| FY 2020 | -$1.62B | -71.3% |
| FY 2019 | -$948.63M | -40.8% |
| FY 2018 | -$673.77M | -623.7% |
| FY 2017 |
BeOne Medicines AG (ONC) reported net income of $286.93M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2014 and fiscal 2025, BeOne Medicines AG's net income grew from -$18.28M to $286.93M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$93.11M |
| +21.9% |
| FY 2016 | -$119.22M | -108.8% |
| FY 2015 | -$57.10M | -212.4% |
| FY 2014 | -$18.28M | - |